Back to Journals » Infection and Drug Resistance » Volume 12

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

Total article views   Abstract views HTML views PDF downloads Totals
1,845 Dovepress* 1,503 227+ 630 1,730
PubMed Central* 0 115 61 115
Totals 1,503 342 691 1,845
*Since 1 April 2019
+Since July 2016

View citations on PubMed Central and Google Scholar